Desmopressin Acetate
Pricing Report NDC 69918-501-05

Latest NADAC: $7.51295 per ML · Effective Jul 19, 2023 · Est. package price $37.56 (5 ML)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Desmopressin Acetate (NDC 69918-501-05) is $7.51295 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 19, 2023.

As a provided by Amring Pharmaceuticals, Inc., this medication is distributed in a 1 BOTTLE, SPRAY in 1 CARTON / 5 mL in 1 BOTTLE, SPRAY configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$7.51295
Per ML

Effective Date
Jul 19, 2023
Billable Units
5 ML
Estimated Package Price
$37.56
Data Status
As of Aug 09, 2023
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE, SPRAY in 1 CARTON / 5 mL in 1 BOTTLE, SPRAY
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Sep 2016, the NADAC wholesale price for (NDC ) has moved within a range of $5.35000 to $23.76835 per ML. Over this 6 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$5.3500 - $23.7684
Market Volatility
344.27% Variance
Latest Trend
40.43%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jul 19, 2023 $7.51295 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 21, 2023 $5.35000 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 17, 2023 $6.30211 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 19, 2023 $8.22213 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 22, 2023 $7.62410 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 22, 2023 $7.50360 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 18, 2023 $7.48643 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 21, 2022 $7.86245 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 23, 2022 $8.39314 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 19, 2022 $9.17318 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 21, 2022 $7.21256 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 17, 2022 $7.49870 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026